Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Overview

About this study

The purpose of this study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Age ≥ 18 years inclusive at the time of signing the ICF

- Allogeneic SCT 90 to 180 days prior to enrollment

- Able to comprehend and willing to provide informed consent

- Willing and able to complete participant-assessment questionnaires either alone or
with minimal assistance from a caregiver and/or trained site personnel

Exclusion Criteria:

- There are no exclusion criteria for this study

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/5/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Mehrdad Hefazi Torghabeh, M.D.	Contact us for the latest status	Contact information: Jordan Scheevel (507) 422-4126 Scheevel.Jordan@mayo.edu
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Saurabh Chhabra, M.B.B.S.	Contact us for the latest status	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015
Jacksonville, Fla. Mayo Clinic principal investigator Madiha Iqbal, M.B.B.S., M.D.	Contact us for the latest status	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mehrdad Hefazi Torghabeh, M.D.

Contact us for the latest status

Contact information:

Jordan Scheevel

(507) 422-4126

Scheevel.Jordan@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Saurabh Chhabra, M.B.B.S.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Jacksonville, Fla.

Mayo Clinic principal investigator

Madiha Iqbal, M.B.B.S., M.D.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Clinical Trials